Emerging Role of GLP-1 Receptor Agonists in Bipolar Disorder Treatment

TL;DR Summary
This review explores the potential of glucagon-like peptide-1 (GLP-1) receptor agonists as emerging treatments for bipolar disorder, summarizing preclinical and clinical evidence supporting their therapeutic role in mood regulation, neuroprotection, and metabolic health.
Topics:technology#bipolar-disorder#clinical-evidence#glp-1-receptor-agonists#medical-research#preclinical-studies#therapeutics
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
43 min
vs 44 min read
Condensed
100%
8,690 → 33 words
Want the full story? Read the original article
Read on Nature